Trinity Biotech Statistics Share Statistics Trinity Biotech has 10.39M
shares outstanding. The number of shares has increased by 3169.42%
in one year.
Shares Outstanding 10.39M Shares Change (YoY) 3169.42% Shares Change (QoQ) 3169.42% Owned by Institutions (%) 0.4% Shares Floating 10.02M Failed to Deliver (FTD) Shares 4,283 FTD / Avg. Volume 0.49%
Short Selling Information The latest short interest is 382.69K, so 1.99% of the outstanding
shares have been sold short.
Short Interest 382.69K Short % of Shares Out 1.99% Short % of Float 2.81% Short Ratio (days to cover) 2.94
Valuation Ratios The PE ratio is -0.5 and the forward
PE ratio is -0.84.
Trinity Biotech's PEG ratio is
0.01.
PE Ratio -0.5 Forward PE -0.84 PS Ratio 0.26 Forward PS 0.1 PB Ratio -0.45 P/FCF Ratio -1.11 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Trinity Biotech.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.28,
with a Debt / Equity ratio of -2.86.
Current Ratio 1.28 Quick Ratio 0.68 Debt / Equity -2.86 Debt / EBITDA -5.96 Debt / FCF -7.07 Interest Coverage -1.77
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $161.99K Profits Per Employee $-83.66K Employee Count 380 Asset Turnover 0.6 Inventory Turnover 2.07
Taxes Income Tax 486K Effective Tax Rate -1.58%
Stock Price Statistics The stock price has increased by -65.29% in the
last 52 weeks. The beta is 0.77, so Trinity Biotech's
price volatility has been higher than the market average.
Beta 0.77 52-Week Price Change -65.29% 50-Day Moving Average 0.7 200-Day Moving Average 0.87 Relative Strength Index (RSI) 68.26 Average Volume (20 Days) 870,698
Income Statement In the last 12 months, Trinity Biotech had revenue of 61.55M
and earned -31.79M
in profits. Earnings per share was -1.8.
Revenue 61.55M Gross Profit 21.44M Operating Income -21.16M Net Income -31.79M EBITDA -16.91M EBIT -18.77M Earnings Per Share (EPS) -1.8
Full Income Statement Balance Sheet The company has 5.17M in cash and 100.76M in
debt, giving a net cash position of -95.6M.
Cash & Cash Equivalents 5.17M Total Debt 100.76M Net Cash -95.6M Retained Earnings -79.12M Total Assets 103.29M Working Capital 9.03M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -4.19M
and capital expenditures -10.06M, giving a free cash flow of -14.26M.
Operating Cash Flow -4.19M Capital Expenditures -10.06M Free Cash Flow -14.26M FCF Per Share -0.79
Full Cash Flow Statement Margins Gross margin is 34.83%, with operating and profit margins of -34.38% and -51.64%.
Gross Margin 34.83% Operating Margin -34.38% Pretax Margin -49.92% Profit Margin -51.64% EBITDA Margin -27.46% EBIT Margin -34.38% FCF Margin -23.16%
Dividends & Yields TRIB pays an annual dividend of $2.2,
which amounts to a dividend yield of 1.23%.
Dividend Per Share $2.20 Dividend Yield 1.23% Dividend Growth (YoY) 0% Payout Ratio -122.22% Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for TRIB.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 23, 2024. It was a
backward
split with a ratio of 1:5.
Last Split Date Feb 23, 2024 Split Type backward Split Ratio 1:5
Scores Altman Z-Score -0.93 Piotroski F-Score 2
